Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1955 1
1956 1
1959 2
1960 2
1963 1
1964 2
1965 1
1966 1
1967 3
1968 1
1969 2
1970 4
1971 3
1973 5
1974 7
1975 5
1976 5
1977 4
1978 2
1979 3
1980 8
1981 6
1982 2
1983 4
1984 7
1985 3
1986 2
1987 3
1988 5
1989 10
1990 10
1991 4
1992 7
1993 2
1994 6
1995 4
1996 5
1997 3
1998 6
1999 7
2000 1
2001 9
2002 7
2003 7
2004 9
2005 8
2006 8
2007 5
2008 5
2009 4
2010 2
2011 1
2012 8
2013 14
2014 7
2015 9
2016 7
2017 7
2018 3
2019 2
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

279 results
Results by year
Filters applied: . Clear all
Page 1
Intravitreal aflibercept for diabetic macular edema.
Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM. Korobelnik JF, et al. Among authors: marcus dm. Ophthalmology. 2014 Nov;121(11):2247-54. doi: 10.1016/j.ophtha.2014.05.006. Epub 2014 Jul 8. Ophthalmology. 2014. PMID: 25012934 Clinical Trial.
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW. Writing Committee for the Diabetic Retinopathy Clinical Research Network, et al. Among authors: marcus dm. JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217. JAMA. 2015. PMID: 26565927 Free PMC article. Clinical Trial.
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial.
Campochiaro PA, Marcus DM, Awh CC, Regillo C, Adamis AP, Bantseev V, Chiang Y, Ehrlich JS, Erickson S, Hanley WD, Horvath J, Maass KF, Singh N, Tang F, Barteselli G. Campochiaro PA, et al. Among authors: marcus dm. Ophthalmology. 2019 Aug;126(8):1141-1154. doi: 10.1016/j.ophtha.2019.03.036. Epub 2019 Apr 1. Ophthalmology. 2019. PMID: 30946888 Free article. Clinical Trial.
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Heier JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, Do DV, Midena E, Boyer DS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Vitti R, Berliner AJ, Zeitz O, Metzig C, Holz FG. Heier JS, et al. Among authors: marcus dm. Ophthalmology. 2016 Nov;123(11):2376-2385. doi: 10.1016/j.ophtha.2016.07.032. Epub 2016 Sep 17. Ophthalmology. 2016. PMID: 27651226 Clinical Trial.
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.
Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J; SCORE2 Investigator Group. Scott IU, et al. Among authors: marcus dm. JAMA. 2017 May 23;317(20):2072-2087. doi: 10.1001/jama.2017.4568. JAMA. 2017. PMID: 28492910 Free PMC article. Clinical Trial.
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF. Brown DM, et al. Among authors: marcus dm. Ophthalmology. 2015 Oct;122(10):2044-52. doi: 10.1016/j.ophtha.2015.06.017. Epub 2015 Jul 18. Ophthalmology. 2015. PMID: 26198808 Clinical Trial.
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial.
Bressler SB, Odia I, Maguire MG, Dhoot DS, Glassman AR, Jampol LM, Marcus DM, Solomon SD, Sun JK; Diabetic Retinopathy Clinical Research Network. Bressler SB, et al. Among authors: marcus dm. JAMA Ophthalmol. 2019 Apr 1;137(4):382-389. doi: 10.1001/jamaophthalmol.2018.6786. JAMA Ophthalmol. 2019. PMID: 30676635 Free PMC article. Clinical Trial.
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ; RIDE and RISE Research Group. Brown DM, et al. Among authors: marcus dm. Ophthalmology. 2013 Oct;120(10):2013-22. doi: 10.1016/j.ophtha.2013.02.034. Epub 2013 May 22. Ophthalmology. 2013. PMID: 23706949 Free article. Clinical Trial.
Hypertensive choroidopathy.
Bourke K, Patel MR, Prisant LM, Marcus DM. Bourke K, et al. Among authors: marcus dm. J Clin Hypertens (Greenwich). 2004 Aug;6(8):471-2. doi: 10.1111/j.1524-6175.2004.3749.x. J Clin Hypertens (Greenwich). 2004. PMID: 15308890 Free article. Review. No abstract available.
279 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page